Analysts have been eager to weigh in on the Healthcare sector with new ratings on Twist Bioscience (TWST) and Infinity Pharma (INFI).
Twist Bioscience (TWST)
In a report released yesterday, Tycho Peterson from J.P. Morgan downgraded Twist Bioscience to Sell, with a price target of $100.00. The company’s shares closed last Monday at $175.38.
According to TipRanks.com, Peterson is a 5-star analyst with an average return of 18.3% and a 68.3% success rate. Peterson covers the Healthcare sector, focusing on stocks such as Intuitive Surgical, Oxford Immunotec, and NanoString Tech.
The word on The Street in general, suggests a Hold analyst consensus rating for Twist Bioscience with a $135.00 average price target.
See today’s analyst top recommended stocks >>
Infinity Pharma (INFI)
Infinity Pharma received a Hold rating from J.P. Morgan analyst Anupam Rama yesterday. The company’s shares closed last Monday at $5.36, close to its 52-week high of $5.49.
According to TipRanks.com, Rama is a 5-star analyst with an average return of 21.7% and a 54.7% success rate. Rama covers the Healthcare sector, focusing on stocks such as Springworks Therapeutics, Apellis Pharmaceuticals, and Frequency Therapeutics.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Infinity Pharma with a $5.67 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
